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Abstract
Background: The overall aim of the study was to explore health care students´ understanding of core concepts
in pharmacology.
Method: An interview study was conducted among twelve students in their final semester of the medical program
(n = 4), the nursing program (n = 4), and the specialist nursing program in primary health care (n = 4) from two Swedish
universities. The participants were individually presented with two pharmacological clinically relevant written
patient cases, which they were to analyze and propose a solution to. Participants were allowed to use the
Swedish national drug formulary. Immediately thereafter the students were interviewed about their assessments. The
interviews were audio-recorded and transcribed verbatim. A thematic analysis was used to identify units of meaning in
each interview. The units were organized into three clusters: pharmacodynamics, pharmacokinetics, and drug
interactions. Subsequent procedure consisted of scoring the quality of students´ understanding of core concepts.
Non-parametric statistics were employed.
Results: The study participants were in general able to define pharmacological concepts, but showed less ability to
discuss the meaning of the concepts in depth and to implement these in a clinical context. The participants found it
easier to grasp concepts related to pharmacodynamics than pharmacokinetics and drug interactions.
Conclusion: These results indicate that education aiming to prepare future health care professionals for understanding
of more complex pharmacological reasoning and decision-making needs to be more focused and effective.
Background
Pharmacotherapy is a cornerstone in the treatment of
many diseases and consequently a large proportion of
the population is prescribed or self-medicates with
pharmaceuticals [1]. Although a variable response to
medications has long been acknowledged, drug ther-
apy has generally employed a broad treatment ap-
proach to a heterogeneous group of patients instead
of a unique treatment approach to an individual patient.
Today the current opinion is, however, that pharmaco-
therapy should as far as possible be adjusted for each pa-
tient [2]. Thus, in the health care setting, more focus
should be attributed to the monitoring and fine-tuning of
drug treatment and to communicate pharmacological is-
sues with individual patients.
During their pharmacological studies health care
students (future physicians, nurses, and specialist
nurses in primary health care, henceforth denoted
“the students”) are exposed to generalized knowledge,
which they must later put into context. The latter
step has proven hard to master, thus hampering the
students’ abilities to identify and handle complex
medication treatments and, in the end, make qualified
judgments and communicate these with patients [3].
Students often struggle when it comes to understand-
ing the subject of pharmacology. It requires, among
other things, that chemical, physiological and math-
ematical thinking are integrated. Because different
groups of health care personnel have different skills
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and roles, overall understanding and communicative
skills in pharmacokinetics/pharmacodynamics are essen-
tial to avoid the risk of incorrect use of medicines [4].
Interactions between simultaneously used drugs are
common causes of undesirable drug-induced events in
patients [5] such as adverse drug effects, insufficient
efficacy or even drug intoxications. These effects
might be explained by the prescriber’s limited know-
ledge of integrated pharmacology resulting in an
inability to customize a drug’s pharmacokinetic or
pharmacodynamics properties to a patient’s specific
conditions [6, 7]. Apart from inter-professional com-
munication and understanding which are crucial, if the
healthcare professional does not have adequate pharmaco-
kinetic and pharmacodynamic insights, trustworthy infor-
mation may not be given to the patient. On the other
hand if the physician/nurse is fully aware of the pharma-
cology of the prescribed drugs and the patient still does
not understand, the explanation might be drawn from in-
adequacies in the communication.
Finally, even though the different disciplines have
separate roles within the health care setting, inter-
professional communication is required to maintain
the quality of care. The outcomes required to obtain
the “Degree of Bachelor of Science in Nursing”
(Nurse), “Postgraduate Diploma in Specialist Nursing:
Primary Health Care” and “Degree of Master of Science
in Medicine” (physician) are specified in Swedish law [8].
Here, it is clearly stated that all three professions are
required, to master relevant aspects of drugs and
drug treatments. For instance, a graduated nurse shall
“demonstrate the ability to manage pharmaceuticals
appropriately and also to inform patients of the ef-
fects and side-effects of pharmaceuticals” as well as
to “demonstrate the ability to apply his or her know-
ledge to deal with different situations, phenomena
and issues on the basis of the needs of individuals
and groups”. Furthermore, graduated specialist nurses
in primary health care, who have (limited) prescrip-
tion rights, shall “demonstrate the ability to observe
and assess complex care, habilitation and rehabilita-
tion needs in patients”. The requirements for medical
graduates are that they should “demonstrate the abil-
ity to initiate and undertake health promotion and
preventive measures in the health care services for
both individuals and groups of patients” and “demon-
strate the ability to integrate and apply knowledge
critically and systematically and also to analyze and
assess complex phenomena, issues and situations”
(translations from The Swedish Council for Higher
Education; https://www.uhr.se/en/start/laws-and-regula-
tions/Laws-and-regulations/The-Higher-Education-Or-
dinance/Annex-2/; accessed 2015-02-18). Thus, while
some differences between the three cohorts studied
regarding the depth of expertise obtained during their
training may be present, the competences needed to deal
with the cases presented could be expected from all three
student groups.
The overall aim of the current study was to explore
health care students’ understanding of core concepts
in pharmacology. Specifically the following questions
were asked: 1. How do students undertaking nursing
and medical educations understand core concepts of
pharmacokinetics, pharmacodynamics and drug inter-
actions? 2. How do the students adapt their pharma-
cological knowledge and apply the understanding of
the core concepts of pharmacokinetics, pharmaco-
dynamics and drug interactions when presented with
two clinically relevant patient cases? (Fig. 1).
Methods
Study subjects
Twelve students in their final semester from the med-
ical program, henceforth abbreviated DOC, nursing
program (RN), and the specialist nursing program in
primary health care (PHCN), were recruited to the
study; four students from each category from two
medical schools in Southern Sweden (Table 1). There
was no intention to compare the performance of stu-
dents from the different universities. The spread of
backgrounds was intended to give a qualitative vari-
ation of the answers given. Students were asked to
voluntarily sign up for participation in the study. All
interviewees gave their informed consent prior to
their inclusion in the study. The current study does
not involve any handling of sensitive personal data or
clinical procedures and therefore no ethical review is
required by law in Sweden according to the Act
(2003:460) concerning the Ethical Review. The project
therefore complies fully with current applicable Swedish
legal rules and ethical guidelines including the Helsinki
declaration.
Case introduction
The students were individually presented with two writ-
ten cases describing patients treated with a combination
of drugs. The cases were designed to imitate common
health care provider-patient interactions. This allows the
students to analyze the problems and to apply their
pharmacological knowledge, acquired from their re-
spective educations, in combination with their infor-
mation collecting skills. Thereby, the depth of the
understanding of the posed problems (Fig. 1) would
be revealed. The first case mainly addressed drug
problems related to pharmacodynamic issues, while
the second was directed towards pharmacokinetic-
related problems. The present paper focuses on the
students’ understanding and ability to articulate the
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pharmacological concepts pharmacodynamics, pharmaco-
kinetics and drug interactions. In a paper we recently
published, we investigated and problematized the pharma-
cological communication within the same setting [9]. The
study participants did not have access to the internet and
the only tool provided was a hardcopy of FASS, the
Swedish national drug formulary which provides health-
care professionals with detailed information about ap-
proved pharmaceuticals. During 30 min (15 min per case)
the student was expected to identify the pharmacological
Fig. 1 The two patient cases that were presented to the interviewees for discussion. Case A The patient is prescribed omeprazole (a proton
pump inhibitor) in combination with the prodrug clopidogrel, an inhibitor of platelet aggregation (P2Y12 purinoceptor antagonist). Since
clopidogrel is activated by an enzyme (CYP2C19) that is inhibited by omeprazole possible effects of an interaction may appear, which
should be considered by the interviewed. Case B The patient is prescribed acetylsalicylic acid (at a low dose) because of cardiovascular
events. The patient wants it to be replaced by another non-steroid, anti-inflammatory drug (NSAID) or paracetamol (acetaminophen). The
discussion of this case requires the understanding of the mechanism of action of NSAIDs (reversible and irreversible cyclooxygenase binding) and its
relevance for the dosage
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problems and find possible solutions. Immediately there-
after, the students discussed the cases for approximately
30 min individually with an interviewer (MR). The inter-
views were semi-structured. All interviewees were
presented with the same patient cases and asked the
same opening questions (Fig. 1) to clarify the mean-
ing of the answers. The intention was to explore the
interviewees´ understanding of the cases given. In the
conversation following the opening questions the student´
s understanding of the concepts of pharmacokinetics,
pharmacodynamics and drug interactions were elicited.
All interviews were audio-recorded and subsequently
transcribed into text. Drugs were referred to primarily by
brand names, rather than generic names, because of the
structure of the FASS drug formulary.
Interview analysis
A thematic analysis was used [10] for identifying and
analyzing patterns or themes in the interviews. The
method allows for working with both a deductive and
inductive approach to the data. The inductive approach
(i.e. without trying to fit into a predefined coding frame)
and the deductive approach (i.e. driven by our analytic
interest) were used iteratively. The analysis consisted of
identifying units of meaning which are coherent and dis-
tinct meanings embedded within the interviews [11]. A
unit of meaning may consist of one word or several sen-
tences. The units were organized in three thematic clus-
ters: pharmacodynamics, pharmacokinetics, and drug
interactions. In a subsequent analysis the quality of the
extracted units of meaning were rated with scores 1–10
(Fig. 2). Two of the authors (GT and MR), independ-
ently, assessed each unit of meaning in all interviews.
The analysis was iterative, and the findings were
reviewed and discussed in order to reach agreement in
understanding of the data.
Statistics
Non-parametric statistics was used and Kruskal-Wallis
analysis was employed when three groups were compared.
Results
All 12 students completed the study. When analyzing
the units of meaning a great variation in students´ an-
swers was observed with regard to the interpretation of
the task, the elaboration and the quality of the reflec-
tions. Results of the quality assessment of units of mean-
ing are graphically presented in Fig. 3. Each student´s
result, including number and quality of statements
(scores 1–10), is displayed in Table 2. Below quotes are
organized to exemplify, in the first part, variation in
quality of reflections and then to illustrate the under-
standing of the core concepts: pharmacodynamics;
pharmacokinetics; and drug interactions.
Table 1 Describing participating students; primary healthcare
nurse students (PHCN), medical students (DOC) and nurse
students (RN)
Future profession Student number
PHCN 1, 2, 3, 4
DOC 5, 6, 7, 12
RN 10, 11, 13, 14
Fig. 2 In the analysis of unites of meaning the quality of each unit was awarded a score from 1–10. The figure displays the competences
expected on each level
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Although most students were able to define terms like
half-life, clearance, distribution volume etc. within the
cases, a number of units of meaning revealed an insufficient
understanding even regarding such important terminology.
The following two quotes illustrate their uncertainty:
“Half-life? Well, that’s tricky. I don’t know if I remember
exactly what sort of stuff that is, ‘cause I failed that topic
on the exam last time…..” (Student No. 2)
and
“I: What do you include into the concept metabolite?
R: It is probably the way it acts…” (Student No. 11)
Such statements are in contrast to the discussion by
other students where they merge and interpret pharma-
codynamic and pharmacokinetic information in order to
explain the situation of the patient.
“Among other things that CYP2C19 was the common
denominator… both go via the CYP450 system but… it
is metabolising if you consider these CYPs, and that in
FASS they specifically dissuades from combining
omeprazole and Plavix (clopidogrel) treatments. It
has been observed that as much as 45 % of the
active aggregation is inhibited, well, Plavix is
inhibited.” (Student No. 12)
The overall evaluation of the units of meaning shows
that the students used the pharmacodynamic informa-
tion at a more advanced level than statements regarding
pharmacokinetics and drug interactions. In the latter
cases, the participants more often made just a simple
definition of the words. Generally, the students tended
to stress the pharmacodynamic topics of the patient
cases over the pharmacokinetic or interaction issues.
When comparing the median scores reached per phar-
macokinetic (PK), pharmacodynamic (PD), and inter-
action (I) units of meaning within each professional
category, pharmacodynamic units of meaning reached
the highest scores for all students; significantly for
PHCN (median values: PK 2; PD 5; I 4; P = 0.002) and
RN students (PK 1.5; PD 5; I 3.5; P = 0.04). For DOC
students, however, pharmacodynamic and pharmacoki-
netic units scored equal whereas units regarding interac-
tions scored lower (PK 5.5; PD 5.5; I 3.2; P = 0.01).
Further, when median scores for pharmacokinetic,
Fig. 3 Graphic overview of the results of the quality of units of meaning (score 1–10 and median). Results related to the core concepts
of pharmacology; pharmacokinetics, pharmacodynamics and drug interactions, subdivided by groups of future health care professionals,
i.e. primary healthcare nurse students (PHCN; ●), medical students (DOC; ■) and nurse students (RN; ▲). n = Number of units of meanings
expressed by each category of future professionals. All participants contributed in each case
Table 2 Number of units of meaning (UM) expressed per
student on the subjects kinetics, dynamics, and drug interaction.
In addition, the median score value per student on respective
subject is presented
PHCN UM Score DOC UM Score RN UM Score
student (n) median student (n) median student (n) median
Kinetics
1 4 5.25 7 4 4.75 13 3 1
2 6 1 12 3 9 14 4 1.25
3 3 3 5 3 6.5 10 4 3.5
4 12 2 6 3 1.5 11 6 4.25
Dynamics
1 5 4.5 6 8 3.5 13 4 6
2 4 2.75 7 5 7 14 4 4.5
3 6 5 12 3 6.5 10 5 5
4 13 5 5 2 4.5 11 8 5
Interaction
1 8 5.75 7 2 6 13 3 1.5
2 4 4 12 2 4.25 14 6 4
3 5 3.5 5 4 1.25 10 1 2.5
4 7 3.5 6 6 2 11 3 5
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pharmacodynamic, and interaction units of meaning
were compared between the professional categories,
DOC scored significantly higher for pharmacokinetics
than did PHCN or RN (PHCN 2; DOC 5.5; RN 1.5;
P = 0.005). No differences were seen between the
students for pharmacodynamics or drug interactions.
Finally, in a comparison of median scores reached per
core pharmacological concept, pharmacodynamics
reached the highest scores, regardless of profession
(PK 2.5; PD 5; I 3.5; P = 0.002). For example, in spite
of omeprazole and clopidogrel interacting at a meta-
bolic level, this was usually not mentioned even
though the efficacy of clopidogrel was discussed.
“Yes… that they interact in some way… I think it is
said that the effect of omeprazole was less good.”
(Student No. 9)
Pharmacodynamics
The participants focused, almost without exception, their
discussions of the cases on the coupling between the
drugs and their pharmacodynamic effects on disease.
Most participants realized the importance of dosage for
the desired effect, as well as for the risks of adverse ef-
fects. Often the effect of the drugs on the disease was
discussed, without any reflection on the mechanisms of
action. For instance, only a few participants discussed
the mechanisms behind the differences in action of the
aspirin-exerted cyclooxygenase (COX)-inhibition in pain
compared to blood clotting. Some participants brought
up the fact that not only the dose, but also the duration
of the effect on the platelets is of importance and one
student suggested incorrect different durations of action
between tablets containing different dosages of acetyl-
salicylic acid.
“… I read that Trombyl (acetylsalicylic acid, 75 mg)
and Magnecyl (acetylsalicylic acid, 500 mg) both
consist of acetylsalicylic acid, which both inhibits
the platelet aggregation, but that Trombyl more
strongly inhibits the platelet aggregation and has a
long-lasting duration for seven to ten days….”
(Student No. 10)
Most did, however, not make this consideration but
regarded the drug effects to be purely dose-correlated
without any confounding factors.
“…and that Magnecyl (acetylsalicylic acid), I think is
500 mg, while Trombyl (acetylsalicylic acid) is 75 mg,
which means it is huge dose of blood-thinning in
Magnecyl and I think this is generally overlooked by
patients. I hadn’t given this a thought before reading it.
So, well, and all these unwanted effects, which appear
mostly from acetylsalicylic acid but also from other
NSAIDs as well.” (Student No. 11)
and
“Well… she mentions them both here, that it is
the same substance, acetylsalicylic acid for
instance, and both are blood-thinners but act in
two different ways. Or Trombyl (acetylsalicylic
acid 75 mg) is blood-thinning, which she takes in
order to prevent stroke and heart infarction and
Magnecyl (acetylsalicylic acid 500 mg) is the actual
painkiller even though it also has a blood-thinning
effect.” (Student No. 2)
and
”… and inform that Trombyl (acetylsalicylic acid
75 mg) and Magnecyl (acetylsalicylic acid 500 mg) are
actually the same thing, but is used for different
reasons and that this is a matter of dose, then I
would also try to explain that they have somewhat
different effects in the body, they inhibit inflammation
and pain but affect the platelets as well and because the
blood-cells live longer, or live for a long time and that
prostaglandins are produced constantly, they can have a
long-lasting effect on some things but a shorter effect on
other things…” (Student No. 7)
Few of the participants realized that Plavix (clopidogrel)
needed to be activated in order to exert its pharmaco-
logical effect.
“But he needs some sort of medicine for this and in
FASS they say that there exists an interaction between
Plavix (clopidogrel) and omeprazole which reduces the
active metabolites” (Student No. 7)
Pharmacokinetics
In contrast to the pharmacodynamic information in
the presented cases, the participants generally seemed
to find it hard to realize the significance of the
pharmacokinetics of the drugs used by the fictive pa-
tients. This is reflected by statements indicating that
using only pharmacodynamic aspects of the drugs is
sufficient to explain the whole situation, which gener-
ally is not the case.
“No. I chose actively not to do it [read about it
pharmacokinetics] since the whole story seems
blurry and I think it is better to straighten out
what it´s all about before one digs in into the
details.” (Student No. 6)
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The clinical relevance of pharmacokinetic data seems
still to be obscure for many participants even though
they may understand the basic meaning of the concepts.
“The half-life is important in order to get a good
dosage regimen, to get a constant flow and in some
way they are merged together so that one does not reflect
as intensively about it, it just goes with the flow when
you read the text… But I do not look into it specifically
or reflect about it.” (Student No. 12)
Only very few made interpretations of the pharmaco-
kinetic data by putting the given situation into new per-
spectives. As written previously, the DOC students
reached higher scores for pharmacokinetic statements
than did the other students.
“Well, the pharmacokinetics depend on what uptake,
metabolism and excretion you have, so there I thought
that he could actually suffer from some newly received
disease or something like that, which could in fact
result in a higher concentration of clopidogrel.”
(Student No. 5)
Drug interactions
When considering the polypharmacy issues of the cases,
problems with drug interactions were often considered
according to the pharmacodynamic effects.
“Since they act on the same systems, both consist of
acetylsalicylic acid, and both will inhibit the platelets,
so they will potentiate each other’s effect, there will be
a double effect on the platelets.” (Student No. 6)
However, some participants considered pharmacokinetic
aspects regarding drug interactions.
“It is quite unclear why omeprazole inhibited Plavix
(clopidogrel) but it was… most things indicated that it
was via CYPC19.” (Student No. 7)
The analysis revealed that most statements made
were of a reproducing nature and only a few dis-
played a deeper understanding of core pharmacology
concepts. This may be depicted in Fig. 3 indicating
that the median ratings rarely were above the threshold.
In general, the students seldom made any further extrapo-
lation of the information for more in-depth discussions.
Discussion
Generally, the participants in this study focused on de-
fining the concepts (pharmacodynamics, pharmacokinet-
ics and interactions) and only to a much lesser extent
used them in further discussions. In the instances when
a more advanced discussion was initiated, the emphasis
was on pharmacodynamic aspects, rather than also tak-
ing pharmacokinetic properties into consideration. Fur-
thermore, it was largely the clinical effects of the drugs
that were looked into, whereas mechanisms of action
etc. were rarely scrutinized. Also, the students had some
capability to extrapolate the meaning of the concepts in
pharmacodynamics and pharmacokinetic aspects when
discussing only one drug at a time. However, only few,
and then often erroneous, statements and interpretations
were made relating to drug interactions. Overall, the stu-
dents seem to have a low ability to apply basic pharma-
cological concepts practically in complex conditions.
Students studying pharmacology often tend to focus
on understanding the mechanism of action of the drug,
whilst the pharmacokinetic course content attracts less
interest [12], which is in line with our results. Pharmaco-
kinetics is often overlooked, in spite of its necessity for
fully grasping the application of pharmacology in the
clinical situation. The similarity in ability to discuss
pharmacodynamic and drug interaction issues is not en-
tirely unexpected. Students consider pharmacodynamic
reasoning to be more intuitive and easier to grasp than
pharmacokinetic reasoning [13]. Drug interactions may,
in this case, be seen as a “mix” of pharmacokinetic and
pharmacodynamic factors interacting. This interplay is
necessary for the student to grasp in order to realize
how to achieve optimal dosing [3, 4].
When interpreting the results of the current study, one
must take into consideration that the number of partici-
pants was quite small and that the selection of the stu-
dents was not randomized. Rather, students were
approached and only those showing interest in participat-
ing in the study were included. One may argue that this
would, perhaps, provide the study with “stronger stu-
dents”, eager to discuss these matters. However, this hy-
pothesis generating study seemed to have functioned well,
since the presented cases triggered all participants to re-
spond irrespective of their education. One reason is prob-
ably that they were presented with two clinically realistic
cases of the kind they would meet in their future everyday
work including layman language like “blood-thinner”.
And in spite of the rather few participants, each one was
able to relate, in one way or another, to the cases, which
resulted in lively discussions rendering a high total num-
ber of statements. In the analysis method that we applied,
all data were considered as one set of transcripts [14] and
by that a large number of statements (units of meaning)
could be analyzed. Furthermore, it was rather obvious that
even though the participants were in the final semester of
their education they considered the interview to be some-
thing of an examination, in which they were eager to pro-
vide the interviewer with correct answers. This may have
hampered their motivation to further expand and deepen
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the discussion into unknown areas. Despite this, if one
may consider the current results to reflect a true situation,
we conclude that the students have an almost acceptable
level of knowledge about the core concepts, but that they
obviously fail in their capability of integrating them in a
pharmacological interpretation.
The results of the current study indicate a gap in the
education between the introduction of the core concepts
of pharmacology and the application of these concepts
in a clinical context, even though the small sample size
employed in the present investigation necessitates cau-
tion when attempting to extrapolate the results to all
health care students. Since the curricula in all programs
represented in the study include both the parts; intro-
duction of concepts and patient cases, the translation of
the concepts into a clinical context is potentially a key
issue [13, 15]. Other studies also indicate that the latter
step is important for a more functional understanding of
pharmacology concepts [16]. Irrespective of pedagogic
approach, more multifaceted pharmacological reasoning
and decision-making ought to be expanded and opti-
mized, with a progressive complexity within respective
curricula. Not only must the extent of the course time
allocated for the basic medical subjects be, if not in-
creased, at least maintained at the current level. If these
concepts are indeed considered important to master in a
modern complex and individualized health care setting,
then efforts must be made to encourage students to
discuss and analyze pharmacological issues beyond a
superficial level. Pharmacological knowledge that takes
account of specific issues regarding pharmacokinetics
and pharmacodynamics will promote long-term health,
safety, ethics and health economics.
Conclusions
In general, the final semester students in this study were
able to define pharmacological concepts, but showed less
ability to discuss the meaning of the concepts in depth
and to interpret the consequences of the given informa-
tion in a clinical context. The participants seemed to ex-
perience pharmacodynamic data to be easier to grasp than
pharmacokinetics. These results indicate that education
aiming to prepare future health care professionals for
more complex pharmacological reasoning and decision-
making should probably be more focused and effective.
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